Methylliberine — Dynamine® (Purine Xanthine · Rapid CNS Stimulation · Adenosine Antagonist)

Compound	Methylliberine (Dynamine®)
Chemical class	Alkaloid — Purine (7-Methyl-1,3,7-trihydro-1,3-dimethyl-2H-purin-2-one derivative; trimethyluric acid related)
CAS	No universal CAS assigned to purified methylliberine
Primary source	Coffea liberica (Liberian coffee), Camellia assamica (Assam tea)
Key applications	Rapid CNS stimulation; lower cardiovascular burden than caffeine; adenosine antagonism; sports/nootropic supplement
Claim strength	Emerging
Typical form	Dynamine® patented ingredient (Compound Solutions); supplement blends (pre-workout, nootropic)
Buy from Herbuno	Request availability and bulk pricing →

Name origin: Methylliberine — from Coffea liberica (the species from which it was characterised) + methyl (the N-methyl substituent distinguishing it from liberine). Also marketed as Dynamine® — a trademark of Compound Solutions (US). Methylliberine is a purine alkaloid closely related to caffeine and theacrine (another naturally occurring methylxanthine from Camellia). It is specifically characterised as having faster onset and shorter duration than caffeine, with purportedly lower cardiovascular stimulation. Traditional use: None specifically. Methylliberine does not have a traditional use history — it was identified and characterised specifically for its supplement potential in the 2010s. Coffea liberica itself has a traditional consumption history in West Africa and Southeast Asia, but methylliberine was not specifically identified as a constituent until recent commercial research. Research trajectory: Methylliberine research is primarily industry-funded and limited. Claims include: faster onset than caffeine (perceived effects within 15 minutes vs caffeine’s 30–60 minutes peak), shorter duration (2–3 hours vs caffeine’s 5–6 hours), less cardiovascular stimulation (lower heart rate and blood pressure increase vs caffeine), and enhanced mood. Mechanistic studies suggest adenosine receptor antagonism (similar to caffeine) with differential receptor subtype selectivity. Commercial source: Not currently in the Herbuno catalogue. Contact Herbuno for availability assessment of methylliberine/Dynamine®.

---

Evidence for Methylliberine Applications

CNS stimulation and alertness: Limited human studies (primarily from Compound Solutions-funded research) show subjective improvements in energy, focus, and mood within 15–30 minutes of ingestion at doses of 100–200 mg. Objective cognitive performance data are limited. The adenosine antagonism mechanism is well-established for the xanthine alkaloid class; whether methylliberine’s specific receptor profile translates to meaningful differentiation from caffeine is not established by independent research. Claim strength: Emerging (limited independent clinical data).

Cardiovascular effects (claimed lower vs caffeine): The claim that methylliberine produces less heart rate increase than caffeine is based on limited comparisons. Some preliminary data suggest lower peak heart rate and blood pressure response at equimolar doses vs caffeine — but the clinical significance and reproducibility require independent replication. Claim strength: Emerging.

Synergy with caffeine and TeaCrine® (theacrine): Methylliberine is most commonly used in combination with caffeine and/or theacrine (another purported “smooth caffeine alternative”) in pre-workout and nootropic supplements. The rationale for these combinations is mechanistically plausible (complementary adenosine receptor effects) but the combination has not been rigorously compared to caffeine alone in controlled trials. Claim strength: Emerging.

---

Frequently Asked Questions — Methylliberine

Is methylliberine the same as Dynamine®?
Dynamine® is the trade name for a standardised methylliberine ingredient produced by Compound Solutions — it is methylliberine (the natural compound) with a proprietary brand attached. The underlying molecule is the same natural xanthine alkaloid found in Liberian coffee and Assam tea. Choosing “Dynamine®” vs generic methylliberine from other suppliers involves considerations of: analytical standardisation, supply reliability, regulatory status, and whether the branded ingredient’s clinical dossier is needed for label claims in the target market.

How does methylliberine compare to theacrine (TeaCrine®)?
Both are purine alkaloids marketed as caffeine alternatives/complements with similar claims (smooth energy, no crash, less cardiovascular stimulation). Theacrine (1,3,7,9-tetramethyluric acid) is found in Camellia assamica and has slightly more human research data than methylliberine, including a multi-dose tolerance study showing no tolerance development over 8 weeks — a significant differentiation from caffeine. Methylliberine is claimed to have faster onset than theacrine. Both are typically combined with caffeine in pre-workout formulations rather than used as standalone caffeine replacements.

Is there a risk of overstimulation or heart issues with methylliberine?
As an adenosine antagonist in the xanthine alkaloid class, methylliberine carries the same class-level concerns as caffeine for cardiovascular stimulation and sleep disruption at high doses. The claim of lower cardiovascular burden vs caffeine has limited independent support. Formulators should apply standard stimulant advisory language: avoid in cardiovascular disease, hypertension, anxiety disorders, during pregnancy, and in children. Do not combine with other stimulants without considering cumulative adenosine antagonist load.

What does the existing science actually show for methylliberine?
Honest summary: methylliberine is a naturally occurring xanthine alkaloid with a well-characterised mechanism (adenosine antagonism). The limited human data are primarily industry-funded, with small sample sizes and short follow-up. The subjective energy and mood improvements reported are consistent with any adenosine antagonist. Independent large-scale trials with objective cognitive and cardiovascular endpoints comparing methylliberine to caffeine do not yet exist. Its commercial success is driven by novel positioning and pre-workout formulation trends rather than a robust independent evidence base.

Related compounds: Caffeine, Theobromine, Theophylline, Piperine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery